New composition of glycoprotein isoforms having follicle...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/24 (2006.01) C07K 14/59 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2181711

The invention is concerned with a mixture of isoforms of a glycoprotein with follicle stimulating activity, a pharmaceutical composition comprising such isoforms as well as a method to induce follicular growth and maturation. Better results were obtained if a pharmaceutical composition with a relatively high proportion of basic isoforms were administered in controlled hyperstimulation. More oocytes could be retrieved and a lower dosage as well as a shorter treatment period sufficed.

L'invention concerne un mélange d'isoformes d'une glycoprotéine à activité folliculo-stimulante, une composition pharmaceutique contenant ce type d'isoformes, ainsi qu'un procédé permettant d'induire la croissance et la maturation folliculaires. On a enregistré de meilleurs résultats dans les cas où la composition pharmaceutique comportait une proportion relativement importante d'isoformes basiques et avait été administrée en hyperstimulation régulée, ce qui avait permis de récupérer davantage d'ovocytes, à un dosage moindre et sur une période de traitement moins étendue.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

New composition of glycoprotein isoforms having follicle... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New composition of glycoprotein isoforms having follicle..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New composition of glycoprotein isoforms having follicle... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1931488

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.